Identification of d-Galactan-III As Part of the Lipopolysaccharide of Klebsiella pneumoniae Serotype O1

is a Gram-negative, ubiquitous bacterium capable of causing severe nosocomial infections in individuals with impaired immune system. Emerging multi-drug resistant strains of this species and particularly carbapenem-resistant strains pose an urgent threat to public health. The lipopolysaccharide (LPS...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in microbiology Vol. 8; p. 684
Main Authors Stojkovic, Katarina, Szijártó, Valéria, Kaszowska, Marta, Niedziela, Tomasz, Hartl, Katharina, Nagy, Gábor, Lukasiewicz, Jolanta
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 25.04.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:is a Gram-negative, ubiquitous bacterium capable of causing severe nosocomial infections in individuals with impaired immune system. Emerging multi-drug resistant strains of this species and particularly carbapenem-resistant strains pose an urgent threat to public health. The lipopolysaccharide (LPS) O-antigen is the main surface antigen. It contributes to the virulence of this species and determines the O-serotype of isolates. Among the nine main O-serotypes of , O1-and O2-type pathogens are causative agents of over 50% of all infections. Serotype O1, the most common O-serotype, expresses complex LPS consisting of d-galactan-I (a polymer built of → 3)-β-d-Gal -(1 → 3)-α-d-Gal -(1 → repeating units) capped by d-galactan-II (built of [ → 3)-α-d-Gal -(1 → 3)-β-d-Gal -(1 →] repeating units). Galactan-I is present as the sole polymer in O2 serotype. Recently, in case of serotype O2, conversion of galactan-I to galactan-III (→ 3)-β-d-Gal -(1 → 3)-[α-d-Gal -(1 → 4)]-α-d-Gal -(1 →) was reported. Substitution of → 3)-α-d-Gal by a branching terminal α-d-Gal was dependent on the presence of the operon and had a major impact on the antigenicity of the galactan polymer. Genetic analysis indicated that 40% of the O1 clinical isolates also carry the locus; therefore we aimed to characterize the corresponding phenotype of LPS O-antigens. The presence of galactan-III among O1 strains was proven using galactan-III-specific monoclonal antibodies and confirmed by structural analyses performed using sugar and methylation analysis as well as classical and high-resolution magic angle spinning NMR spectroscopy. By using an isogenic mutant pair, we demonstrated that galactan-III expression was dependent on the presence of glycosyltransferases encoded by , as was shown previously for the O2 serotype. Furthermore, the galactan-II structures in O1 + strains remained unaffected corroborating no functional interactions between the biosynthesis of galactan-III and galactan-II polymers.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by: Dongsheng Zhou, Beijing Institute of Microbiology and Epidemiology, China
Reviewed by: Nikolay Nifantiev, N.D. Zelinsky Institute of Organic Chemistry (RAS), Russia; Marta Palusinska-Szysz, Maria Curie-Skłodowska University, Poland
This article was submitted to Infectious Diseases, a section of the journal Frontiers in Microbiology
ISSN:1664-302X
1664-302X
DOI:10.3389/fmicb.2017.00684